Holen Sie sich die Stockscreener-App
85.27
1.30%
-1.12
Handel nachbörslich:
85.27
Schlusskurs vom Vortag:
$86.39
Offen:
$88.47
24-Stunden-Volumen:
295.85K
Relative Volume:
0.76
Marktkapitalisierung:
$1.42B
Einnahmen:
$5.93B
Nettoeinkommen (Verlust:
$-405.35M
KGV:
-3.5024
EPS:
-24.3461
Netto-Cashflow:
$-148.87M
1W Leistung:
-3.32%
1M Leistung:
+225.33%
6M Leistung:
+413.44%
1J Leistung:
+53.64%
1-Tages-Spanne:
$81.87
$89.00
1-Wochen-Bereich:
$74.55
$89.65
52-Wochen-Spanne:
$7.48
$90.48
Agilon Health Inc Stock (AGL) Company Profile
Firmenname
Agilon Health Inc
Sektor
Branche
Telefon
562-256-3800
Adresse
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
85.27 | 1.44B | 5.93B | -405.35M | -148.87M | -24.35 |
HCA
Hca Healthcare Inc
|
392.42 | 87.42B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
176.38 | 14.97B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
195.57 | 12.74B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.58 | 11.62B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.91 | 10.41B | 6.07B | 793.80M | 464.40M | 5.9914 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-25 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-04-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-01-10 | Eingeleitet | Needham | Hold |
| 2024-12-16 | Eingeleitet | Macquarie | Neutral |
| 2024-12-11 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-11-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-04-22 | Eingeleitet | Citigroup | Neutral |
| 2024-03-06 | Eingeleitet | Barclays | Underweight |
| 2024-02-26 | Herabstufung | Jefferies | Buy → Hold |
| 2024-02-26 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-05 | Herabstufung | Truist | Buy → Hold |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Eingeleitet | The Benchmark Company | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | In-line |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-09-14 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-09-12 | Eingeleitet | Goldman | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-06-24 | Eingeleitet | BTIG Research | Neutral |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-10-20 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-05-11 | Eingeleitet | William Blair | Outperform |
| 2021-05-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-10 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-10 | Eingeleitet | Goldman | Buy |
| 2021-05-10 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-10 | Eingeleitet | Truist | Buy |
| 2021-05-10 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-10 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Agilon Health Inc Aktie (AGL) Neueste Nachrichten
Agilon Health Hits Day High with Strong 7.22% Intraday Surge - Markets Mojo
7 Small-Cap Stocks More Than Doubled In May: Micron Did Only 46% - Benzinga
Agilon Health Analyst Ratings and Price Targets | NYSE:AGL - Benzinga
Agilon Health Inc (AGL) Stock Price, Quote, News & History - Benzinga
Benchmark Co. Maintains Agilon Health(AGL.US) With Buy Rating, Raises Target Price to $95 - Moomoo
AGL Stock Price, Quote & Chart | AGILON HEALTH INC (NYSE:AGL) - ChartMill
Q1 Earnings Highs And Lows: Select Medical (NYSE:SEM) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo! Finance Canada
AGL Maintained by Benchmark -- Price Target Lowered to $95.00 - GuruFocus
Agilon Health (AGL) Appoints Tim O’Rourke as Chief Executive Officer - Insider Monkey
Why Kulicke And Soffa Industries Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - Sahm
Dow Dips 350 Points; US Foods Posts Downbeat Earnings - Sahm
Top 2 Health Care Stocks That May Plunge This Month - Benzinga
Agilon Health’s SWOT analysis: stock faces profitability pressures By Investing.com - Investing.com South Africa
Agilon Health’s SWOT analysis: stock faces profitability pressures - Investing.com
Leerink raises agilon health stock price target to $92 on cost trends By Investing.com - Investing.com South Africa
Agilon Health (AGL) Gets a Hold from Truist Financial - The Globe and Mail
Leerink raises agilon health stock price target to $92 on cost trends - Investing.com Nigeria
Truist reiterates Hold on agilon health stock with $67 target - Investing.com UK
Truist reiterates Hold on agilon health stock with $67 target By Investing.com - Investing.com South Africa
What's going on with Agilon Health stock Friday? - MSN
Agilon Health Q1 2026 Results: Revenue Beat, EBITDA Surge, and Full-Year Outlook RaisedNews and Statistics - IndexBox
5 Revealing Analyst Questions From agilon health’s Q1 Earnings Call - Yahoo Finance
AGL Maintains Rating by Citigroup -- Price Target Raised to $80. - GuruFocus
Agilon Health Is Maintained at Neutral by Citigroup - Moomoo
Bernstein raises Agilon Health stock price target on improved results - Investing.com India
NYSE New 52-Week Highs And Lows - Moomoo
Agilon Health Price Target Raised to $80.00/Share From $18.75 by Citigroup - Moomoo
Citi Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $80 - Moomoo
Bernstein raises Agilon Health stock price target on improved results By Investing.com - Investing.com Nigeria
Agilon Health (AGL) price target increased by 50.63% to 30.22 - MSN
AQR Holdings reports 974,897-share, 5.87% stake in agilon health (AGL) - Stock Titan
Agilon Health stock reaches 52-week high at 72.48 USD By Investing.com - Investing.com South Africa
Agilon Health stock reaches 52-week high at 72.48 USD - Investing.com
Goldman Sachs (NYSE: GS) discloses 1.02M-share, 6.1% stake in Agilon Health - Stock Titan
Finanzdaten der Agilon Health Inc-Aktie (AGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.01%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):